Marked Weight Loss Found in Assisted Living Residents During Quarantine
Nearly half of patients at assisted living facilities showed significant weight loss early during the COVID-19 pandemic.
Weight Management
Guideline for Preventing Weight Gain in Women at Midlife
Panel recommends counseling all women aged 40 to 60 years on healthy eating and physical activity to maintain weight or prevent weight gain.
Weight-Loss Program Based on the 5As Framework Shows Success in College Students
Effective weight-management resources were delivered to more than 75% of college students with a high BMI within 90 days.
Qsymia Approved for Chronic Weight Management in Pediatric Patients
The approval was based on data from a phase 4 study which included patients 12 to 17 years of age with a BMI at the 95th percentile or greater standardized for age and sex.
Efficacy of GLP-1 Agonists for Weight Loss in Adults Without Diabetes
Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.
Study Dispels Myths on Intermittent Fasting for Weight Loss
Intermittent fasting produces similar weight loss as traditional diets and is generally safe, producing few gastrointestinal, neurologic, hormonal, or metabolic effects.
How Can Women Prevent Weight Gain in Menopause?
Researchers delineate strategies to prevent weight gain and body composition changes among women during perimenopause and menopause.
Intermittent Fasting Effective for Weight Loss in Adults With Obesity
Intermittent fasting has demonstrated health benefits in a number of randomized clinical trials. Researchers sough to directly link specific health outcomes from these trials in people with overweight or obesity.
Semaglutide for Weight Loss
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist primarily used to improve glycemic control in adults with type 2 diabetes. One favorable side effect of semaglutide is weight loss, and researchers have now studied its use in adults with overweight or obesity and without diabetes.
Semaglutide Superior to Liraglutide for Weight Loss
Findings reported for subcutaneous treatment in overweight, obese adults also using diet, physical activity.
- Loading...
Loading...
Next post in Obesity Information Center
Loading... 
Loading...